RGEN Repligen Corp

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

$187.38  -3.68 (-1.93%)
As of 09/30/2022 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  03/05/2001
Outstanding shares:  55,491,199
Average volume:  455,378
Market cap:   $10,602,148,481
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2731654
Valuation   (See tab for details)
PE ratio:   71.21
PB ratio:   5.87
PS ratio:   14.44
Return on equity:   8.25%
Net income %:   19.86%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy